Literature DB >> 21119696

Blood phenylalanine control in phenylketonuria: a survey of 10 European centres.

K Ahring1, A Bélanger-Quintana, K Dokoupil, H Gokmen-Ozel, A M Lammardo, A MacDonald, K Motzfeldt, M Nowacka, M Robert, M van Rijn.   

Abstract

BACKGROUND: Only limited data are available on the blood phenylalanine (Phe) concentrations achieved in European patients with phenylketonuria (PKU) on a low-Phe diet.
OBJECTIVE: A survey was conducted to compare blood Phe control achieved in diet-treated patients with PKU of different age groups in 10 European centres.
METHODS: Centres experienced in the management of PKU from Belgium, Denmark, Germany, Italy, The Netherlands, Norway, Poland, Spain, Turkey and the United Kingdom provided retrospective audit data of all patients with PKU treated by diet over a 1-year period. Standard questions were used to collect median data on blood Phe concentrations, percentage of blood Phe concentrations below upper target reference ranges and frequency of blood Phe sampling.
RESULTS: Data from 1921 patients on dietary management were included. Blood Phe concentrations were well controlled and comparable across centres in the early years of life. The percentages of blood Phe concentrations meeting each centre's local and national target ranges were 88% in children aged up to 1 year, 74% for 1-10 years, 89% for 11-16 years and 65% for adults (>16 years). The frequency of home blood sampling, compared with local and national recommendations for monitoring Phe concentrations, appeared to decline with age (from approximately 100% in infancy to 83% in teenagers and 55% in adults).
CONCLUSIONS: Although blood Phe control generally deteriorated with age, some improvement was observed in adolescent years across the 10 European centres. The blood Phe control achieved seemed comparable in many of the European centres irrespective of different dietary treatments or national policies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21119696     DOI: 10.1038/ejcn.2010.258

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  24 in total

1.  Successful Live Birth following Preimplantation Genetic Diagnosis for Phenylketonuria in Day 3 Embryos by Specific Mutation Analysis and Elective Single Embryo Transfer.

Authors:  Stuart Lavery; Dima Abdo; Mara Kotrotsou; Geoff Trew; Michalis Konstantinidis; Dagan Wells
Journal:  JIMD Rep       Date:  2012-03-31

Review 2.  Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan.

Authors:  Lin Mei; Peipei Song; Norihiro Kokudo; Lingzhong Xu; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2013-11

Review 3.  Up to date knowledge on different treatment strategies for phenylketonuria.

Authors:  Amaya Bélanger-Quintana; Alberto Burlina; Cary O Harding; Ania C Muntau
Journal:  Mol Genet Metab       Date:  2011-08-16       Impact factor: 4.797

4.  Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.

Authors:  T Mlčoch; R Puda; P Ješina; M Lhotáková; Š Štěrbová; T Doležal
Journal:  Eur J Clin Nutr       Date:  2017-06-28       Impact factor: 4.016

5.  Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2019-05-03       Impact factor: 3.183

6.  Management of adult patients with phenylketonuria: survey results from 24 countries.

Authors:  Friedrich K Trefz; Francjan J van Spronsen; Anita MacDonald; François Feillet; Ania C Muntau; Amaya Belanger-Quintana; Alberto Burlina; Mübeccel Demirkol; Marcello Giovannini; Christoph Gasteyger
Journal:  Eur J Pediatr       Date:  2014-12-06       Impact factor: 3.183

7.  Phenylketonuria: nutritional advances and challenges.

Authors:  Marcello Giovannini; Elvira Verduci; Elisabetta Salvatici; Sabrina Paci; Enrica Riva
Journal:  Nutr Metab (Lond)       Date:  2012-02-03       Impact factor: 4.169

8.  Phenylketonuria screening and management in southeastern Europe - survey results from 11 countries.

Authors:  Mojca Zerjav Tansek; Urh Groselj; Natalija Angelkova; Dana Anton; Ivo Baric; Maja Djordjevic; Lindita Grimci; Maria Ivanova; Adil Kadam; Vjosa Kotori; Hajrija Maksic; Oana Marginean; Otilia Margineanu; Olivera Miljanovic; Florentina Moldovanu; Mariana Muresan; Michaela Nanu; Mira Samardzic; Vladimir Sarnavka; Aleksei Savov; Maja Stojiljkovic; Biljana Suzic; Radka Tincheva; Husref Tahirovic; Alma Toromanovic; Natalia Usurelu; Tadej Battelino
Journal:  Orphanet J Rare Dis       Date:  2015-05-30       Impact factor: 4.123

9.  Overweight and obesity in PKU: The results from 8 centres in Europe and Turkey.

Authors:  H Gokmen Ozel; K Ahring; A Bélanger-Quintana; K Dokoupil; A M Lammardo; M Robert; J C Rocha; M F Almeida; M van Rijn; A MacDonald
Journal:  Mol Genet Metab Rep       Date:  2014-11-16

10.  Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.

Authors:  Tobias S Hagedorn; Paul van Berkel; Gregor Hammerschmidt; Markéta Lhotáková; Rosalia Pasqual Saludes
Journal:  Orphanet J Rare Dis       Date:  2013-12-17       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.